Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Phase IV study of trifluridine/tipiracil on quality of life in metastatic colorectal cancer
2017-000292-83Phase 4Completed
- Sponsor
- Servier
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of trifluridine + tipiracil in colorectal cancer (CRC) (2 arms), sponsored by Servier. Primary endpoint: Rate of responders with continued unchanged or improved HRQoL. Started Jun 2017; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-000292-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000292-83.